See More Treatments
See all treatments in the PatientsLikeMe system shared by patients just like you.
Carbidopa-Levodopa Treatment Report
Brand Names:
Sinemet, Carbidopa-Levodopa 25-100, Sinemet Plus, Sinemet 25/250
What is Carbidopa-Levodopa? Levodopa is a dopamine precursor used to treat the movement disorder symptoms of Parkinson's disease. Carbidopa is often included with levodopa-containing drugs in order to boost its efficacy by slowing down the metabolism of dopamine.
See more information, including instructions, precautions, side effects, and interactions.
Reasons taken
25 patients in the community are taking or have taken Carbidopa-Levodopa.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Treat my MSA | 10 | 40% |
| Other | 5 | 20% |
| Intention tremors - shaking when performing fine movements | 2 | 8% |
| Support another treatment | 1 | 4% |
| To treat PD | 1 | 4% |
| Treat Parkinonism Issues | 1 | 4% |
| Treat Parkinson's | 1 | 4% |
| Balance problems | 1 | 4% |
| general freezing of entire body | 1 | 4% |
Other treatments patients are taking for Treat my MSA include Urinary Catheter, Swallow Evaluation, and Wheelchair (manual).
Dosages
Based on the patients currently taking Carbidopa-Levodopa.
Top 10 (Show all)
All (Show top 10)
| 25mg-100mg as needed | 2 x 25 mg-100 mg all the time (24/7) | 25 mg-100 mg daily | 2 x 10 mg-100 mg daily | 3 x 25 mg-100 mg daily | 4 x 25 mg-100 mg daily | 5 x 25 mg-100 mg daily | 500.5 mg daily | 6 x 25 mg-100 mg daily | 8 x 25 mg-100 mg daily | 9 x 25 mg-100 mg daily | 1000 mg daily | 4 x 25 mg-250 mg daily | 5 x 25 mg-250 mg daily | 18 x 25 mg-250 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1
|
1
|
2
|
1
|
3
|
4
|
1
|
1
|
1
|
1
|
1
|
1
|
4
|
2
|
1
|
||
Duration
How long current patients have been taking Carbidopa-Levodopa or how long patients were taking Carbidopa-Levodopa before stopping.
Currently Taking Carbidopa-Levodopa
Stopped Taking Carbidopa-Levodopa
Patient Reported Evaluations
Results from 8 patient evaluations. See the overall results and all individual evaluations.
Efficacy (Effect based on reason taken)
| Major | 50% | 2 |
|---|---|---|
| Moderate | 25% | 1 |
| None | 25% | 1 |
Treat my MSA
Side-effects (as an overall problem)
| Severe | 13% | 1 |
|---|---|---|
| Moderate | 38% | 3 |
| Mild | 13% | 1 |
| None | 38% | 3 |
Top reported side-effects include: Dyskinesia, Nausea, Drowsiness
Summary results are based on 8 individual responses. For more information, see overall results for Adherence, Burden and Cost.
Individual Patient Reported Evaluations (2 of 8)
-
- RebeccaJean
- Sex: F
- Mood: Very bad
- Cognition: Severe
- Autonomic: Severe
- Head: severe
- Arms: severe
- Legs: severe
- Tremors: moderate
- See profile
-
by RebeccaJean
Mar 13, 2007
- EfficacyNone
- Side-effectsModerate
- Treat my MSA
- See full evaluation
-
0 helpful marks
-
- btrflynana2
- Sex: F
- Mood: Very bad
- Cognition: Moderate
- Autonomic: Moderate
- Head: none
- Arms: none
- Legs: moderate
- Tremors: none
- See profile
-
by btrflynana2
Nov 23, 2008
- EfficacyMajor
- Side-effectsNone
- Treat my MSA
- See full evaluation
-
0 helpful marks
Report created on November 07, 2009.